Casilda Llácer Pérez

机构：Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga · ORCID：0000-0002-4107-5522

发表论文 16 篇 · 总被引 41 次 · h-index 3

代表论文

Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study (2025 · Journal of Thoracic Oncology · 被引 16)
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A (2025 · Clinical Cancer Research · 被引 12)
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer (2023 · Clinical Cancer Research · 被引 11)
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations (2025 · JCO Precision Oncology · 被引 2)
Supplementary Data 1 from A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer (2025)
Data from Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A (2025)